Development of Peptidomimetic Inhibitors Targeting the Polo Box Domain of PLK1 as Potential Cancer Therapeutics
Theses and Dissertations
Part of the Pharmacy and Pharmaceutical Sciences Commons
Part of the Pharmacy and Pharmaceutical Sciences Commons